Dataiku accelerates AI development in biotechnology

Have a specific question? Query our research catalogue with the Nucleus AI Tool.

Biotechnology and pharmaceutical companies face mounting pressure to deliver innovative treatments faster and more cost-effectively. As such, the integration of advanced data science tools has become essential to ensure proper clinical design and facilitate complex analyses. To investigate the value delivered by these tools, Nucleus interviewed multiple biotechnology and pharmaceutical companies that adopted Dataiku. Organizations reported multiple tangible benefits, including 18 to 43 percent time savings across data teams, 52 percent faster AI model development, and significantly reduced costs in clinical testing.

Learn more about Nucleus Research’s ROI case study approach here.

Gain the knowledge you need to effectively develop and deliver a financial business case at ROIUniversity.com.